Interleukin-2-Associated Bullous Drug Dermatosis
Authors:
- M. HofmannMHM. Hofmann
- H. AudringHAH. Audring
- W. SterryWSW. Sterry
- U. TrefzerUTU. Trefzer
- 1 December 2004
- journal article
- letter
- Published by S. Karger AG in Dermatology
- Vol. 210 (1) , 74-75
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cutaneous side effects of clinically relevant cytokine therapiesDMW - Deutsche Medizinische Wochenschrift, 2003
- Interleukin-2 associated linear IgA bullous dermatosisJournal of the American Academy of Dermatology, 1996
- Cutaneous reactions to recombinant cytokine therapyJournal of the American Academy of Dermatology, 1995
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Recurrence of pemphigus vulgaris associated with interleukin 2 therapyArchives of Dermatology, 1994
- Cutaneous side effects associated with interleukin 2 administration for metastatic melanomaJournal of the American Academy of Dermatology, 1993
- Interleukin-2-Induced Dermatotoxicity Resembling Toxic Epidermal NecrolysisSouthern Medical Journal, 1992
- Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five casesArchives of Dermatology, 1992
- Pemphigus and Bullous Pemphigoid due to DrugsInternational Journal of Dermatology, 1991
- Life-Threatening Bullous Skin Eruptions During Interleukin-2 TherapyJNCI: Journal of the National Cancer Institute, 1991